Final Results from the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression

1. Bardia, A.
2. Rugo, H.S.
3. Tolaney, S.M.
4. Loirat, D.
5. Punie, K.
6. Oliveira, M.
7. Brufsky, A.
8. Kalinsky, K.
9. Cortes, J.
10. Shaughnessy, J.O.
11. Dieras, V.
12. Carey, L.A.
13. Gianni, L.
14. Piccart-Gebhart, M.
15. Loibl, S.
16. Yoon, O.K.
17. Pan, Y.
18. Hofsess, S.
19. Phan, S.-C.
20. Hurvitz, S.A.